FDA Issues Proposed Patient Medication Information Rule
Earlier this summer, the United States Food and Drug Administration (FDA) released a long-awaited proposed rule regarding the…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Study Finds that Physicians Receiving Remuneration Were More Likely to Give…
Recently, JAMA Internal Medicine published “Association Between Pharmaceutical Industry Marketing Payments to Physicians and…
CMS Issues Proposed Rule Regarding Medicaid Drug Rebate Program
In late-May, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule entitled Misclassification of Drugs,…
CMMI Update on Health Equity
In October of 2021, the CMS Center for Medicare and Medicaid Innovation (CMMI) unveiled its 2030 vision to achieve “equitable…
CMS Set to Scrutinize Medicare Advantage Marketing
In a May 10 letter to Medicare Advantage organizations and prescription drug plans, CMS said it will more closely scrutinize more…
Novartis Executives Cleared of Bribery Allegations
Four former Novartis executives were recently cleared of bribery charges after a seven-year investigation into allegations that…
San Francisco and Walgreens Reach $230 Million Settlement Over Opioid…
San Francisco recently reached a nearly $230 million settlement with Walgreens Boots Alliance Inc over its alleged role in the…
Gilead Succeeds in HIV Drug Patent Case Against the Government
After a weeklong trial, a federal jury ruled against the federal government, finding that Gilead Sciences Inc. did not infringe…
FTC Deepens Probe into Pharmacy Benefit Managers
Recently, the United States Federal Trade Commission (FTC) announced that it would expand its probe into pharmacy benefit managers…
Policy and Medicine Compliance Update July 2023 Issue Features: HHS OIG…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…